Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche.

Nat Commun

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.

Published: April 2023

AI Article Synopsis

  • Limited access to hematopoietic stem cells (HSCs) hampers the broader application of HSC therapies, necessitating better methods for their expansion.
  • The study introduces a biomimetic Microniche system that effectively expands HSCs, particularly those favoring the creation of megakaryocytes, and showcases successful implementation in a stirred bioreactor.
  • Key findings reveal that the productive megakaryocyte-biased HSCs can be identified within a specific subpopulation, and the advancement in HSC expansion is attributed to an optimized microenvironment that provides essential cytokines and physical support.

Article Abstract

Limited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34CD38CD45RA-CD90CD49f CD62LCD133 subpopulation. Specifically, the expansion of megakaryocyte-biased HSCs is supported by a biomimetic niche-like microenvironment, which generates a suitable cytokine milieu and supplies the appropriate physical scaffolding. Thus, beyond clarifying the existence and immuno-phenotype of human megakaryocyte-biased HSC, our study demonstrates a flexible human HSC expansion strategy that could help realize the strong clinical promise of HSC-based therapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113370PMC
http://dx.doi.org/10.1038/s41467-023-37954-3DOI Listing

Publication Analysis

Top Keywords

human megakaryocyte-biased
12
hsc expansion
12
hematopoietic stem
8
stem cells
8
biomimetic microniche
8
hsc-based therapies
8
human hsc
8
megakaryocyte-biased hsc
8
megakaryocyte-biased hscs
8
expansion
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!